Revance Therapeutics Inc. (RVNC)
NASDAQ: RVNC
· Real-Time Price · USD
3.65
0.00 (0.00%)
At close: Feb 05, 2025, 3:59 PM
Revance Therapeutics Revenue
Revance Therapeutics reported an annual revenue of $234.04M, reflecting a 76.55% growth. For the quarter ending September 30, 2024, Revance Therapeutics generated $59.88M in revenue.
Revenue (ttm)
234.04M
Revenue Growth
76.55%
Price / Sales Ratio
3.18
Revenue / Employee
392.03K
Employees
597
Market Cap
381.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 234.04M | +76.55% |
| Dec 31, 2022 | 132.56M | +70.40% |
| Dec 31, 2021 | 77.8M | +407.65% |
| Dec 31, 2020 | 15.32M | +3610.65% |
| Dec 31, 2019 | 413K | -88.92% |
| Dec 31, 2018 | 3.73M | +1323.28% |
| Dec 31, 2017 | 262K | -12.67% |
| Dec 31, 2016 | 300K | n/a |
| Dec 31, 2015 | 300K | -21.67% |
| Dec 31, 2014 | 383K | -37.93% |
| Dec 31, 2013 | 617K | -13.95% |
| Dec 31, 2012 | 717K | +28.73% |
| Dec 31, 2011 | 557K | n/a |